In this executive interview with Drug Development & Delivery, Adare Pharma Solutions CEO Tom Sellig shares his perspective on the rapidly evolving CDMO landscape and the technologies shaping its future. From the growing role of AI and 3D printing to the increasing demand for high-potency capabilities and integrated services, Sellig outlines how innovation, strategic investment, and adaptability are helping drive more efficient drug development and bring therapies to patients faster.
